Fucidin 250 mg Tablets
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC-36306427
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Fucidin 250 mg Tablets | PL: 00043/5000 | Sodium Fusidate | 05702191000931 |
Batches (expiry): D00993 (31/01/2026)
Background: LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing. Advice for Healthcare Professionals Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.